Stonebridge Financial Planning Group’s First Trust NYSE Arca Biotechnology Index Fund FBT Stock Holding History

Stonebridge Financial Planning Group’s Portfolio FBT Stock Details FBT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q1	–	Sell	-1,295	Closed	-$188K	–	186
2021 Q4	$188K	Sell	1,295 -810	-38%	-$131K	0.1%	124
2021 Q3	$358K	Sell	2,105 -510	-20%	-$87.1K	0.18%	95
2021 Q2	$447K	Sell	2,615 -415	-14%	-$68.5K	0.24%	77
2021 Q1	$478K	Sell	3,030 -160	-5%	-$27.4K	0.28%	67
2020 Q4	$536K	Sell	3,190 -85	-3%	-$13.8K	0.34%	56
2020 Q3	$526K	Buy	3,275 +715	+28%	+$117K	0.38%	55
2020 Q2	$437K	Buy	2,560 +1,650	+181%	+$259K	0.37%	55
2020 Q1	$126K	Buy	910 +50	+6%	+$7.12K	0.13%	107
2019 Q4	$128K	Buy	+860	New	+$118K	0.12%	113

Other funds holding FBT

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

RJFSA

Raymond James Financial Services Advisors St. Petersburg, Florida $75.1B AUM 31.89% 1-Year Est. Return

LPL Financial San Diego, California $377B AUM 19.32% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

BFG

Berger Financial Group Plymouth, Minnesota $1.79B AUM 15.72% 1-Year Est. Return

RJA

Raymond James & Associates St Petersburg, Florida $164B AUM 33.91% 1-Year Est. Return

Commonwealth Equity Services Waltham, Massachusetts $71.6B AUM 21.08% 1-Year Est. Return

Stonebridge Financial Planning Group's FBT Position: Q1 2022 in Review

Stonebridge Financial Planning Group sold out of First Trust NYSE Arca Biotechnology Index Fund (FBT) in Q1 2022, closing a stake of 1,295 shares — an estimated $188K sold.

Stonebridge Financial Planning Group first reported a position in FBT in Q4 2019 and held it in 9 quarters. The position peaked at $536K in Q4 2020. 220 funds tracked by Wall St. Rank hold FBT as of Q1 2022.

Stonebridge Financial Planning Group reported no remaining First Trust NYSE Arca Biotechnology Index Fund position as of Q1 2022 after selling out during the quarter.
Stonebridge Financial Planning Group sold 1,295 First Trust NYSE Arca Biotechnology Index Fund shares in Q1 2022, an estimated $188K.
Stonebridge Financial Planning Group first reported a position in First Trust NYSE Arca Biotechnology Index Fund in Q4 2019 and held it in 9 quarters.
Stonebridge Financial Planning Group's First Trust NYSE Arca Biotechnology Index Fund position peaked at $536K in Q4 2020.
220 funds tracked by Wall St. Rank held First Trust NYSE Arca Biotechnology Index Fund as of Q1 2022.

Based on Stonebridge Financial Planning Group's 13F filing for Q1 2022, filed 10 May 2022.